| 英文别名 |
Androstenedione;4-Androstene-3,17-dione;4-androstenedione;Androst-4-ene-3,17-dione;1-Pyrrolidinobutyronitrile;ANDERSTERODIONE;Androstenedione solution;Delta-4-Androstene-3,17-Dione;Androtex;3,17-Dioxoandrost-4-ene;delta-4-Androstenedione;SKF 2170;Fecundin;Androstendione;17-Ketotestosterone;d4-androstenedione;Androstenedione [JAN];MLS000028510;Delta(;3,17-Dioxoandrost-4-Ene;Androstenedione (CRM);Testosterone EP Impurity A;4-Androstene-3;4-androsten-3,17-dione (4-AD);4-Androstene-3,17-dione Solution, 100ppm;4-androstene-3,17-dione(4-AD);4-Androstenedione;4-Androstenedione(4AD);VS-12118;ANDROSTENEDIONE [VANDF];androstenedione;4-ANDROSTENE-3-17-DIONE;Androst-4-ene-3,17-dione; 17-Ketotestosterone; Androstenedione; 4-Androstene-3,17-dione; 4-Androstenedione;Epitope ID:135869;NCGC00254238-01;(3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-dione;DELTA4-Androstene-3,17-dione;MLS000563086;UNII-409J2J96VR;CS-T-30659;C00280;delta(sup 4)-Androstene-3,17-dione;.delta.-(sup4)-Androsten-3,17-dione;EU-0100114;AKOS005622710;Delta(4)-androstene-3,17-dione;.DELTA.4-Androstene-3,17-dione;NSC9563;D0O3GO;(4)-Androsten-3,17-dione;LMST02020007;NCGC00023902-04;Spectrum5_002059;NCGC00023902-03;409J2J96VR;[4-14C]-androstenedione;Delta(4)-androsten-3,17-dione;FT-0657562;Androsten-3,17-dione;delta-4-Androstene-3,17-dione;AC-33197;NSC-9563;HMS2231F18;androst-4-ene-3,17-dione (androstenedione);BDBM91713;Testosterone EP Impurity A;D4-Androstene-3,17-dione;LS-2167;AC-11042;STK801871;CCG-204209;Androst-4-en-3,17-dione, 2;4-Androstene-3,17-dione, VETRANAL(TM), analytical standard;NCGC00259818-01;SMR000058281;[4-14C]androst-4-ene-3,17-dione;D00051;ANDROSTENEDIONE [WHO-DD];D0M8RO;NCGC00023902-06;Tox21_300579;BBL033517;(8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione;TESTOSTERONE IMPURITY A [EP IMPURITY];SR-01000075697-1;Opera_ID_1694;(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione;Q411064;BIDD:PXR0101;androst-4-en-3,17-dione;NCGC00023902-07;Androstenedione, 1mg/ml in Methanol;Tox21_202269;(8R,10R,13S)-10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione;A 9630;D03TIX;NCGC00023902-08;ANDROSTENEDIONE [MI];SCHEMBL23272;Tox21_110893;delta4-androstenedione;117598-81-9;Androstenedione; 3,17-Dioxo-4-andostene;NSC 9563;Androst-4-ene-3,17-diona;DTXSID8024523;MLS002152886;Lopac0_000114;GTPL2860;Testosterone Imp. A (EP): Androst-4-ene-3,17-dione (Androste;delta-(sup4)-Androsten-3,17-dione;WLN: L E5 B666 FV OV MUTJ A1 E1;63-05-8;NCGC00023902-05;.delta.4-Androsten-3,17-dione;SR-01000003096;Tox21_110893_1;W-104936;Androstenedione (JAN);DB01536;SR-01000075697;CHEMBL274826;adione;delta-4-Androsten-3,17-dione;HSDB 7335;EINECS 200-554-5... |
